{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:11:52Z","timestamp":1794507112475,"version":"4.9.1"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Fracture repair involves the reactivation of developmental signaling cascades, including Wnt signaling that stimulates bone formation and bone regeneration. Rodent data indicate that dual inhibition of the Wnt signaling antagonists sclerostin and Dickkopf-1 (DKK1) increases callus bone volume and strength while increasing bone mass systemically.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We evaluated the effects of 16 weeks of subcutaneously administered carrier solution (vehicle, VEH), anti-sclerostin antibody (Scl-Ab), anti-DKK1 antibody (DKK1-Ab), or Scl-Ab plus DKK1-Ab combination therapy (COMBO) on ulnar osteotomy healing in nonhuman primates (cynomolgus monkeys; 20 to 22 per group).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Scl-Ab and COMBO therapy increased systemic markers of bone formation versus VEH, with COMBO leading to synergistic increases versus Scl-Ab or DKK1-Ab monotherapies. The COMBO and Scl-Ab groups showed reduced serum markers of bone resorption versus VEH. The COMBO and DKK1-Ab groups exhibited greater callus bone mineral density (BMD), torsional stiffness, and torsional rigidity versus VEH. Lumbar vertebrae from the Scl-Ab and COMBO groups showed greater BMD and bone formation rate versus VEH, and the femoral mid-diaphysis of the Scl-Ab and COMBO groups showed greater periosteal and endocortical bone formation rates versus VEH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>DKK1-Ab increased BMD and strength at the ulnar osteotomy site, Scl-Ab increased bone formation and BMD at uninjured skeletal sites, and Scl-Ab plus DKK1-Ab combination therapy induced all of these effects, in some cases to a greater degree versus 1 or both monotherapies. These results in nonhuman primates suggest that DKK1 preferentially regulates bone healing while sclerostin preferentially regulates systemic bone mass.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Relevance:<\/jats:title>\n                    <jats:p>Combination therapy with antibodies against sclerostin and DKK1 may offer a promising therapeutic strategy for both fracture treatment and fracture prevention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2106\/jbjs.22.01092","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T01:11:55Z","timestamp":1683767515000},"page":"1145-1155","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["Dual Inhibition of the Wnt Inhibitors DKK1 and Sclerostin Promotes Fracture Healing and Increases the Density and Strength of Uninjured Bone"],"prefix":"10.2106","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6203-2038","authenticated-orcid":false,"given":"Monica","family":"Florio","sequence":"first","affiliation":[{"name":"Discovery Research, Amgen, Thousand Oaks, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7209-1368","authenticated-orcid":false,"given":"Paul J.","family":"Kostenuik","sequence":"additional","affiliation":[{"name":"Discovery Research, Amgen, Thousand Oaks, California"},{"name":"Phylon Pharma Services, Thousand Oaks, California"},{"name":"University of Michigan School of Dentistry, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6114-8779","authenticated-orcid":false,"given":"Marina","family":"Stolina","sequence":"additional","affiliation":[{"name":"Discovery Research, Amgen, Thousand Oaks, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2684-3244","authenticated-orcid":false,"given":"Franklin J.","family":"Asuncion","sequence":"additional","affiliation":[{"name":"Discovery Research, Amgen, Thousand Oaks, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2818-2497","authenticated-orcid":false,"given":"Mario","family":"Grisanti","sequence":"additional","affiliation":[{"name":"Discovery Research, Amgen, Thousand Oaks, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2883-9134","authenticated-orcid":false,"given":"Hua Zhu","family":"Ke","sequence":"additional","affiliation":[{"name":"Discovery Research, Amgen, Thousand Oaks, California"},{"name":"Angitia Biopharmaceuticals, Guangzhou, Guangdong, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9563-414X","authenticated-orcid":false,"given":"Michael S.","family":"Ominsky","sequence":"additional","affiliation":[{"name":"Discovery Research, Amgen, Thousand Oaks, California"},{"name":"Ascendis Pharma, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,5,9]]},"reference":[{"issue":"12","key":"bib1-20250430","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1359\/jbmr.070802","article-title":"Bone regeneration is regulated by wnt signaling","volume":"22","author":"Kim","year":"2007","journal-title":"J Bone Miner Res."},{"issue":"5","key":"bib2-20250430","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1210\/er.2011-1060","article-title":"Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases","volume":"33","author":"Ke","year":"2012","journal-title":"Endocr Rev."},{"issue":"5","key":"bib3-20250430","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","article-title":"Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)","volume":"10","author":"Balemans","year":"2001","journal-title":"Hum Mol Genet."},{"issue":"23","key":"bib4-20250430","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","article-title":"Osteocyte control of bone formation via sclerostin, a novel BMP antagonist","volume":"22","author":"Winkler","year":"2003","journal-title":"EMBO J."},{"issue":"6","key":"bib5-20250430","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.080216","article-title":"Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength","volume":"23","author":"Li","year":"2008","journal-title":"J Bone Miner Res."},{"issue":"2","key":"bib6-20250430","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1365-2141.2009.07587.x","article-title":"Platelet is a major contributor to circulating levels of Dickkopf-1: clinical implications in patients with multiple myeloma","volume":"145","author":"Voorzanger-Rousselot","year":"2009","journal-title":"Br J Haematol."},{"issue":"4","key":"bib7-20250430","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.bone.2006.03.017","article-title":"Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia","volume":"39","author":"Li","year":"2006","journal-title":"Bone."},{"issue":"6","key":"bib8-20250430","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1359\/jbmr.060311","article-title":"Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass","volume":"21","author":"Morvan","year":"2006","journal-title":"J Bone Miner Res."},{"issue":"7","key":"bib9-20250430","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1371\/journal.pmed.0040249","article-title":"Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing","volume":"4","author":"Chen","year":"2007","journal-title":"PLoS Med."},{"issue":"11","key":"bib10-20250430","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1002\/jbmr.472","article-title":"Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injury","volume":"26","author":"Li","year":"2011","journal-title":"J Bone Miner Res."},{"issue":"4","key":"bib11-20250430","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/jbmr.3036","article-title":"Romosozumab improves bone mass and strength while maintaining bone quality in ovariectomized cynomolgus monkeys","volume":"32","author":"Ominsky","year":"2017","journal-title":"J Bone Miner Res."},{"issue":"5","key":"bib12-20250430","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/jbmr.14","article-title":"Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength","volume":"25","author":"Ominsky","year":"2010","journal-title":"J Bone Miner Res."},{"issue":"4","key":"bib13-20250430","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1359\/jbmr.081206","article-title":"Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis","volume":"24","author":"Li","year":"2009","journal-title":"J Bone Miner Res."},{"issue":"16","key":"bib14-20250430","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N Engl J Med."},{"issue":"15","key":"bib15-20250430","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N Engl J Med."},{"issue":"2","key":"bib16-20250430","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00223-017-0275-2","article-title":"Sclerostin antibody increases callus size and strength but does not improve fracture union in a challenged open rat fracture model","volume":"101","author":"Morse","year":"2017","journal-title":"Calcif Tissue Int."},{"issue":"1","key":"bib17-20250430","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.intimp.2014.11.010","article-title":"Systemic administration of sclerostin monoclonal antibody accelerates fracture healing in the femoral osteotomy model of young rats","volume":"24","author":"Feng","year":"2015","journal-title":"Int Immunopharmacol."},{"issue":"8","key":"bib18-20250430","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/jor.22636","article-title":"Sclerostin monoclonal antibody enhanced bone fracture healing in an open osteotomy model in rats","volume":"32","author":"Suen","year":"2014","journal-title":"J Orthop Res."},{"issue":"5","key":"bib19-20250430","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/jbmr.307","article-title":"Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones","volume":"26","author":"Ominsky","year":"2011","journal-title":"J Bone Miner Res."},{"issue":"5","key":"bib20-20250430","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3109\/17453674.2011.625539","article-title":"Anti-sclerostin antibody and mechanical loading appear to influence metaphyseal bone independently in rats","volume":"82","author":"Agholme","year":"2011","journal-title":"Acta Orthop."},{"issue":"9","key":"bib21-20250430","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1177\/0022034518766874","article-title":"Sclerostin and DKK1 inhibition preserves and augments alveolar bone volume and architecture in rats with alveolar bone loss","volume":"97","author":"Liu","year":"2018","journal-title":"J Dent Res."},{"key":"bib22-20250430","doi-asserted-by":"crossref","first-page":"11505","DOI":"10.1038\/ncomms11505","article-title":"A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair","volume":"7","author":"Florio","year":"2016","journal-title":"Nat Commun."},{"issue":"8","key":"bib23-20250430","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2106\/JBJS.L.00285","article-title":"Systemic administration of sclerostin antibody enhances bone repair in a critical-sized femoral defect in a rat model","volume":"95","author":"Virk","year":"2013","journal-title":"J Bone Joint Surg Am."},{"issue":"2","key":"bib24-20250430","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/jor.22498","article-title":"Evaluation of the effects of systemic treatment with a sclerostin neutralizing antibody on bone repair in a rat femoral defect model","volume":"32","author":"Alaee","year":"2014","journal-title":"J Orthop Res."},{"issue":"9","key":"bib25-20250430","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/jbmr.3454","article-title":"Sclerostin neutralizing antibody treatment enhances bone formation but does not rescue mechanically induced delayed healing","volume":"33","author":"Kruck","year":"2018","journal-title":"J Bone Miner Res."},{"issue":"8","key":"bib26-20250430","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2106\/JBJS.19.00790","article-title":"A randomized, placebo-controlled study of romosozumab for the treatment of hip fractures","volume":"102","author":"Schemitsch","year":"2020","journal-title":"J Bone Joint Surg Am."},{"issue":"16","key":"bib27-20250430","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.2106\/JBJS.19.01008","article-title":"Romosozumab in skeletally mature adults with a fresh unilateral tibial diaphyseal fracture: A randomized phase-2 study","volume":"102","author":"Bhandari","year":"2020","journal-title":"J Bone Joint Surg Am."},{"issue":"5","key":"bib28-20250430","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.bone.2011.02.008","article-title":"The effects of Dickkopf-1 antibody on metaphyseal bone and implant fixation under different loading conditions","volume":"48","author":"Agholme","year":"2011","journal-title":"Bone."},{"key":"bib29-20250430","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bone.2014.07.039","article-title":"Anti-DKK1 antibody promotes bone fracture healing through activation of \u03b2-catenin signaling","volume":"71","author":"Jin","year":"2015","journal-title":"Bone."},{"issue":"8","key":"bib30-20250430","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1161\/ATVBAHA.109.189761","article-title":"Dickkopf-1 enhances inflammatory interaction between platelets and endothelial cells and shows increased expression in atherosclerosis","volume":"29","author":"Ueland","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"6","key":"bib31-20250430","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1159\/000358303","article-title":"Serum levels of sclerostin and dickkopf-1: effects of age, gender and fracture status","volume":"60","author":"Dovjak","year":"2014","journal-title":"Gerontology."},{"key":"bib32-20250430","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bone.2014.07.031","article-title":"Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized rats","volume":"67","author":"Stolina","year":"2014","journal-title":"Bone."},{"key":"bib33-20250430","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2015.12.013","article-title":"Time-dependent cellular and transcriptional changes in the osteoblast lineage associated with sclerostin antibody treatment in ovariectomized rats","volume":"84","author":"Taylor","year":"2016","journal-title":"Bone."},{"key":"bib34-20250430","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bone.2017.11.003","article-title":"Dampening of the bone formation response following repeat dosing with sclerostin antibody in mice is associated with up-regulation of Wnt antagonists","volume":"107","author":"Holdsworth","year":"2018","journal-title":"Bone."},{"issue":"5","key":"bib35-20250430","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2106\/00004623-199505000-00010","article-title":"Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates","volume":"77","author":"Cook","year":"1995","journal-title":"J Bone Joint Surg Am."},{"issue":"4","key":"bib36-20250430","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/jor.1100170422","article-title":"Novel formulation of fibroblast growth factor-2 in a hyaluronan gel accelerates fracture healing in nonhuman primates","volume":"17","author":"Radomsky","year":"1999","journal-title":"J Orthop Res."},{"issue":"2","key":"bib37-20250430","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1210\/jcem.86.2.7199","article-title":"Acceleration of fracture healing in nonhuman primates by fibroblast growth factor-2","volume":"86","author":"Kawaguchi","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"bib38-20250430","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.2106\/00004623-200409000-00015","article-title":"Recombinant human bone morphogenetic protein-2 delivered in an injectable calcium phosphate paste accelerates osteotomy-site healing in a nonhuman primate model","volume":"86","author":"Seeherman","year":"2004","journal-title":"J Bone Joint Surg Am."},{"issue":"1","key":"bib39-20250430","first-page":"144","article-title":"rhBMP-2\/calcium phosphate matrix accelerates osteotomy-site healing in a nonhuman primate model at multiple treatment times and concentrations","volume":"88","author":"Seeherman","year":"2006","journal-title":"J Bone Joint Surg Am."},{"issue":"6","key":"bib40-20250430","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.bone.2007.01.015","article-title":"Human parathyroid hormone (1-34) accelerates natural fracture healing process in the femoral osteotomy model of cynomolgus monkeys","volume":"40","author":"Manabe","year":"2007","journal-title":"Bone."},{"issue":"2","key":"bib41-20250430","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1124\/jpet.111.181404","article-title":"A rate-limiting role for Dickkopf-1 in bone formation and the remediation of bone loss in mouse and primate models of postmenopausal osteoporosis by an experimental therapeutic antibody","volume":"338","author":"Glantschnig","year":"2011","journal-title":"J Pharmacol Exp Ther."},{"issue":"3","key":"bib42-20250430","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1359\/jbmr.081104","article-title":"Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma","volume":"24","author":"Heath","year":"2009","journal-title":"J Bone Miner Res."},{"issue":"9","key":"bib43-20250430","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/jbmr.3735","article-title":"Bone-forming and antiresorptive effects of romosozumab in postmenopausal women with osteoporosis: Bone histomorphometry and microcomputed tomography analysis after 2 and 12 months of treatment","volume":"34","author":"Chavassieux","year":"2019","journal-title":"J Bone Miner Res."},{"key":"bib44-20250430","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bonr.2018.03.002","article-title":"Differential time-dependent transcriptional changes in the osteoblast lineage in cortical bone associated with sclerostin antibody treatment in ovariectomized rats","volume":"8","author":"Taylor","year":"2018","journal-title":"Bone Rep."}],"container-title":["Journal of Bone and Joint Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.22.01092","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:44:45Z","timestamp":1787751885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.22.01092"}},"subtitle":["An Experimental Study in Nonhuman Primates"],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":44,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2106\/jbjs.22.01092","relation":{},"ISSN":["0021-9355","1535-1386"],"issn-type":[{"value":"0021-9355","type":"print"},{"value":"1535-1386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,9]]}}}